Indoor Harvest Corp. (OTCPK:INQD) announced the acquisition of a 60% controlling interest in Metabiogenix USA for $2.5 million in a combination of cash and common stock. During the close of the acquisition, Metabiogenix USA received a valuation of $8.9 million from the Japanese Medical Institute.
“This acquisition will provide Indoor Harvest an exclusive agreement to market and distribute the portfolio of Metabiogenix USA Nutraceuticals throughout the entire Western Hemisphere (North, South, and Central America), and Spain. Metabiogenix USA is on track for substantial growth and projecting revenues that could be as high as $20 million for FY2024” stated Leslie Bocskor, chairman & CEO of INQD. “Words cannot express the …